MSL
EBS icon

Mackay Shields LLC’s Emergent Biosolutions EBS Stock Holding History

Mackay Shields LLC’s Portfolio EBS Stock Details EBS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-15,740
Closed -$1.46M – 881
2021
Q1 		$1.46M Sell
15,740
-10,737
-41% -$1.1M 0.01% 885
2020
Q4 		$2.37M Sell
26,477
-3,886
-13% -$357K 0.02% 791
2020
Q3 		$3.14M Buy
30,363
+2,386
+9% +$257K 0.02% 594
2020
Q2 		$2.21M Sell
27,977
-1,600
-5% -$119K 0.02% 705
2020
Q1 		$1.71M Sell
29,577
-1,600
-5% -$92.2K 0.02% 732
2019
Q4 		$1.68M Sell
31,177
-8,300
-21% -$450K 0.01% 934
2019
Q3 		$2.06M Sell
39,477
-3,000
-7% -$140K 0.01% 887
2019
Q2 		$2.05M Buy
42,477
+25,937
+157% +$1.24M 0.01% 888
2019
Q1 		$836K Sell
16,540
-1,800
-10% -$106K 0.01% 1054
2018
Q4 		$1.09M Sell
18,340
-4,440
-19% -$286K 0.01% 907
2018
Q3 		$1.5M Buy
22,780
+7,200
+46% +$420K 0.01% 781
2018
Q2 		$787K Sell
15,580
-2,000
-11% -$104K 0.01% 1016
2018
Q1 		$926K Buy
+17,580
New +$876K 0.01% 994

Other funds holding EBS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return
Manulife (Manufacturers Life Insurance)
Manulife (Manufacturers Life Insurance) Canada, Ontario, Canada $116B AUM 26.37% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Mackay Shields LLC's EBS Position: Q2 2021 in Review

Mackay Shields LLC sold out of Emergent Biosolutions (EBS) in Q2 2021, closing a stake of 15,740 shares — an estimated $1.46M sold.

Mackay Shields LLC first reported a position in EBS in Q1 2018 and held it in 13 quarters. The position peaked at $3.14M in Q3 2020. 290 funds tracked by Wall St. Rank hold EBS as of Q2 2021.

  • Mackay Shields LLC reported no remaining Emergent Biosolutions position as of Q2 2021 after selling out during the quarter.
  • Mackay Shields LLC sold 15,740 Emergent Biosolutions shares in Q2 2021, an estimated $1.46M.
  • Mackay Shields LLC first reported a position in Emergent Biosolutions in Q1 2018 and held it in 13 quarters.
  • Mackay Shields LLC's Emergent Biosolutions position peaked at $3.14M in Q3 2020.
  • 290 funds tracked by Wall St. Rank held Emergent Biosolutions as of Q2 2021.

Based on Mackay Shields LLC's 13F filing for Q2 2021, filed 13 Aug 2021.